Navigation Links
Neurobiological Technologies, Inc. Reports First Quarter Fiscal Year 2009 Financial Results
Date:11/6/2008

- FINANCIAL TABLES TO FOLLOW -

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(in thousands, except per share data)

Three months ended

September 30,

2008 2007

REVENUES

Royalty $2,078 $1,981

Technology sale and collaboration services 1,487 1,919

Total revenues 3,565 3,900

EXPENSES

Research and development 5,452 5,460

General and administrative 1,331 1,659

Total expenses 6,783 7,119

Operating loss (3,218) (3,219)

Interest income 249 28

Gain on sale of long-term investments 170 --

Interest expense, including non-cash

amortization of $588 discount on

notes for the three months ended

September 30, 2007 -- (633)

Non-cash gain on decrease in fair

value of warrants 37 2,902

NET LOSS $(2,762) $(922)

BASIC AND DILUTED NET LOSS PER SHARE $(0.10) $(0.19)

Shares used in basic and diluted net loss

per share calculation 26,924 4,772

SELECTED CONSOLIDATED BALANCE SHEET DATA

(in thousands)

September 30, June 30,


'/>"/>

SOURCE Neurobiological Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Neurobiological Technologies to Present at the Rodman & Renshaw 10th Annual Healthcare Conference in New York on November 10
2. Neurobiological Technologies Sets Date for First Quarter Financial Results
3. Neurobiological Technologies Reports Receipt of $2 Million Royalty Payment for Quarterly Sales of Memantine
4. Neurobiological Technologies to Present at the BIO Investor Forum in San Francisco on October 30, 2008
5. Neurobiological Technologies Announces Update Call on Viprinex (TM) Phase 3 Trial Program
6. Neurobiological Technologies, Inc. (Nasdaq: NTII) Q4/08 Review Issued by Scimitar Equity, LLC
7. Neurobiological Technologies Announces Dates for 2008 Fiscal Year End Financial Results Conference Call and Presentation at MCF Investor Summit
8. Neurobiological Technologies Reports Receipt of $2.1 Million Royalty Payment for Quarterly Sales of Memantine
9. Neurobiological Technologies CEO to Retire on December 31, 2008
10. Neurobiological Technologies Reports Third Quarter Financial Results
11. Neurobiological Technologies Sets Date for Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015 Knowledgent , ... paper that explores the potential of big data analytics ... paper was developed to help life sciences and healthcare ... data to gain critical business insights. , The life ... of data driven by patient profiling, compliance and regulatory ...
(Date:5/21/2015)... MO (PRWEB) May 21, 2015 Seventh ... the safety and efficacy of pharmaceutical products and medical ... Maryland Heights, MO 63043, a 50,000 sq. ft. building ... location, to enable strategic growth. Facility renovations will begin ... the new space will occur in September. , ...
(Date:5/21/2015)... 21, 2015  Prima Biomed Ltd. (NASDAQ: PBMD ... to become a leader in the development of immunotherapeutic ... the final CVac data from the Phase II CAN-003 ... for a clinically meaningful improvement in Overall Survival ("OS") ... In the group of second remission patients ...
(Date:5/21/2015)... Imagine being able to probe ... of others. Being able to read faces and enjoy ... to anticipate their thoughts and actions like never before. ... to create unique abstract paintings and video, or, play ... a first-person-shooter as it creates action, dialog, and outcomes ...
Breaking Biology Technology:New White Paper Explores the Potential of Big Data Analytics in Life Sciences and Healthcare 2Seventh Wave Laboratories Purchases Building for Expansion, Upcoming Move 2Seventh Wave Laboratories Purchases Building for Expansion, Upcoming Move 3Correction Continues after Big Move - BrokerBank Securities, Inc. 25 Days to Meet ARGUS - The World's First Contactless Emotions Scanner 2
... a,specialist in antibiotics development, announces that Dr. George ... the Company., Dr. Golumbeski brings to the ... recently as Vice President of Business Development,Licensing & ... In this,position he was responsible for the full ...
... July 2 /Xinhua-PRNewswire-FirstCall/,-- China Pharma Holdings, Inc. (,China ... markets generic and branded bio-,pharmaceutical products in China, ... Collins Stewart Fourth Annual Growth Conference on Tuesday,July ... being held at the Mandarin,Oriental Hotel in New ...
... new therapies based on cells manufactured from ... provide funding round, SALT LAKE CITY and HAMBURG, ... the forefront of innovative cell therapies,for the treatment of ... Series A financing. The round was led by SV ...
Cached Biology Technology:Nabriva Therapeutics Announces Appointment of New CEO 2China Pharma Holdings, Inc. to Present at Collins Stewart Fourth Annual Growth Conference in New York on July 8, 2008 at 2:00 p.m. EDT 2AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury 2AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury 3
(Date:5/19/2015)... , May 19, 2015  Technology is rapidly advancing, ... and in the cloud. Passwords and their management are ... OTP and standards-based specifications such as those developed by ... use of passwords presents for BYOD, COPE, IoT, and ... biometric identity protocol. In response to ...
(Date:5/14/2015)... May 14, 2015 Research and Markets ... "Fingerprint Sensors Market in Smart Mobile Devices " ... believes that 2014 was a watershed year for fingerprint ... of ,Apple Pay,. Apple gave fingerprint sensors a raison ... service. Fingerprint sensors are a must-have feature in flagship ...
(Date:5/11/2015)...  Through a well-rounded UAS delegation representing private industry, government, ... showing at AUVSI,s Unmanned 2015 conference last week in ... UAS industry met with over 200 hundred people ... the UAS ecosystem. "Our message is clear ... Aerospace Rich Knoll . "If you want to fly ...
Breaking Biology News(10 mins):HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2
... salvia magnesium acetate, is a phenolic acid compound ... of caffeic acid. Salvianolic acid B exerts strong ... improves energy metabolism against cerebral ischemia-reperfusion injuries. Dr. ... Xiangya Hospital, Central South University, China found that ...
... word, object, or picture) is called item memory while memory ... is defined as source memory. What determines which sources within ... researchers. Behavioral evidence suggests that the orientation of a memory ... be remembered later. A study by Prof. Xiuyan Guo and ...
... look at the basic biology of a fungus that is ... report that they can find little that might stop the ... Their report appears in the journal PLOS ... ( Geomyces ) destructans causes white-nose syndrome ...
Cached Biology News:Fungus that causes white-nose syndrome in bats proves hardy survivor 2Fungus that causes white-nose syndrome in bats proves hardy survivor 3
... DNA aptamer screening and binding optimization and ... microfluidic on-chip synthesis platform. Thousands of customer ... LC Sciences can provide assistance with custom ... part of our comprehensive DNA/RNA Aptamer Microarray ...
... The LX80L is an extension of Parkers MX80 ... a compact cross-section. LX80L bolt hole patterns mimic ... MX80 units and all accessory brackets to build ... with travel to 750 mm , Accelerations to ...
... Cell Kit with Medium High quality ready-to-use ... optimized base medium for growth and lineage ... cells generated from E18 fetal rat brain ... tissue-like mixture of in vitro stem/progenitor cells, ...
... the use of small interfering RNA (siRNA) ... RNA interference,(RNAi) pathway have generated tremendous interest ... siRNA for experimental use can be,synthesized in ... transfected into the target cells in vitro ...
Biology Products: